期刊文献+

肝细胞癌和胆管细胞癌活体氢质子磁共振波谱分析 被引量:6

In Vivo Proton Magnetic Resonance Spectroscopy of Hepatocellular Carcinoma and Cholangiocarcinoma
下载PDF
导出
摘要 目的利用氢质子磁共振波谱分析肝细胞癌和胆管细胞癌代谢物变化。方法对正常对照组、病理证实的肝细胞癌和胆管细胞癌患者分别进行1.5T氢质子磁共振波谱检查,计算位于3.2ppm的胆碱峰(Cho)与位于1.3ppm的脂酯峰(Lip)的相对浓度(Cho/Lip)。结果正常肝脏、病理证实的胆管细胞癌及肝细胞癌的Cho/Lip分别为0.07±0.04、0.11±0.06和0.52±0.15,肝细胞癌的Cho/Lip显著高于正常对照和胆管细胞癌(P<0.05),正常肝脏和胆管细胞癌的Cho/Lip差异无显著性(P>0.05)。结论活体氢质子波谱分析可以从代谢水平反映肝细胞癌和胆管细胞癌病理变化情况,为临床诊断提供参考。 Objective To investigate the value of in vivo proton magnetic resonance spectroscopy ( ^1 H MRS) in the assessment of hepatocellular carcinoma (HCC) and cholangiocarcinoma. Methods 1H MRS was performed in normal volunteers and in patients with pathologically confirmed HCC and cholangiocarcinomas using a whole-body 1.5-T scanner. The choline-to-lipid ratios were measured by dividing the peak area of choline at 3.2 ppm and lipid at 1.3 ppm. Results The ratio of choline-to-lipid for normal liver, cholangiocarcinomas, and HCC were 0.07 ± 0.04, 0. 11 ± 0. 06, and 0.52 ± 0. 15, respectively. The ratio of choline-to- lipid was significantly higher in HCC compared than those in cholangiocarcinomas or normal livers ( P 〈 0. 05 ) However, it was not significantly different between cholangiocarcinomas and normal livers ( P 〉 0.05 ). Conclusion In vivo ^1H MRS can reflect the pathological changes of HCC and cholangiocarcinomas at metabolic level and thus is useful in the diagnosis of these two cancers.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2009年第2期151-154,I0001,共5页 Acta Academiae Medicinae Sinicae
基金 国家自然科学基金(30670590)~~
关键词 磁共振波谱分析 胆管细胞癌:肝细胞癌 magnetic resonance spectroscopy cholangiocarcinoma hepatocellular carcinoma
  • 相关文献

参考文献12

  • 1张向华,岳根洲,张劲松,彭勇,王永宏,宦怡.肝内胆管细胞癌的CT表现[J].实用放射学杂志,2007,23(12):1647-1648. 被引量:5
  • 2肖运平,肖恩华,梁斌,田蕾萁.周围型肝内胆管细胞癌的影像学表现与病理对照分析[J].实用放射学杂志,2006,22(8):952-955. 被引量:41
  • 3Inglese M, Li BS, Rusinek H, et al. Diffusely elevated cerebral choline and creatine in relapsing remitting multiple sclerosis [J]. Magn Resort Med, 2003, 50(1) :190-195.
  • 4Law M, Cha S, Knopp EA, et al. High-gradegliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging [J]. Radiology, 2002, 222(3) :715-721.
  • 5Yeung DK, Yang WT, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases [ J ]. Radiology, 2002, 225 ( 1 ) : 190-197.
  • 6Coakley FV, Qayyum A, Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer [J]. J Urol, 2003, 110(6 Pt2) :S69-S75.
  • 7Taylor-Robinson SD, Sargentoni J, Bell JD, et al. In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver [ J ]. Liver, 1997, 11(4) :198-209.
  • 8Cho SG, Kim MY, Kim HJ, et al. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings [ J]. Radiology, 2001, 221 (3) :740-746.
  • 9Cox IJ, Menon DK, Sargentoni J, et al. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques [ J]. J Hepatol, 1992, 14 (2-3) :265-275.
  • 10Dixon RM. NMR studies of phospholipid metabolism in hepatic lymphoma [ J ]. NMR Biomed, 1998, 11 ( 7 ) : 370- 379.

二级参考文献11

共引文献43

同被引文献49

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部